Molecular and Cellular Biology, May 2000, p. 3705-3714, Vol. 20, No. 10
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Division of Basic Science, National Cancer Institute,1 and National Institute of Diabetes, Digestive, and Kidney Diseases,4 National Institutes of Health, Bethesda, Maryland 20892; Department of Biological Sciences, Stanford University, Stanford, California 943052; and Indiana University Cancer Center/Walther Oncology Center and Department of Microbiology, Indiana University School of Medicine, Indianapolis, Indiana 462023
Received 14 January 2000/Returned for modification 17 February 2000/Accepted 22 February 2000
| |
ABSTRACT |
|---|
|
|
|---|
Human cells lacking functional p53 exhibit a partial deficiency in nucleotide excision repair (NER), the pathway for repair of UV-induced DNA damage. The global genomic repair (GGR) subpathway of NER, but not transcription-coupled repair (TCR), is mainly affected by p53 loss or inactivation. We have utilized mouse embryo fibroblasts (MEFs) lacking p53 genes or downstream effector genes of the p53 pathway, gadd45 (Gadd45a) or p21 (Cdkn1a), as well as MEFs lacking both gadd45 and p21 genes to address the potential contribution of these downstream effectors to p53-associated DNA repair. Loss of p53 or gadd45 had a pronounced effect on GGR, while p21 loss had only a marginal effect, determined by measurements of repair synthesis (unscheduled DNA synthesis), by immunoassays to detect removal of UV photoproducts from genomic DNA, and by assays determining strand-specific removal of CPDs from the mouse dhfr gene. Taken together, the evidence suggests a role for Gadd45, but relatively little role for p21, in DNA repair responses to UV radiation. Recent evidence suggests that Gadd45 binds to UV-damaged chromatin and may affect lesion accessibility. MEFs lacking p53 or gadd45 genes exhibited decreased colony-forming ability after UV radiation and cisplatin compared to wild-type MEFs, indicating their sensitivity to DNA damage. We provide evidence that Gadd45 affects chromatin remodelling of templates concurrent with DNA repair, thus indicating that Gadd45 may participate in the coupling between chromatin assembly and DNA repair.
| |
INTRODUCTION |
|---|
|
|
|---|
The tumor suppressor p53 is an important mediator of cellular responses to DNA damage in mammalian cells. In some cell types, p53 activation triggers apoptosis (30), while in other cell types, p53 serves a protective function, attributable not only to the activation of cell cycle checkpoints, but also enhancement of DNA repair (12; reviewed recently in reference 41). P53 plays a role in nucleotide excision repair (NER), the pathway for repair of UV-induced DNA damage, bulky carcinogen adducts, and DNA damage caused by cancer chemotherapy agents such as cis-dichloro-diammine-platinum (cisplatin) (see references 11-13 and 38-41 and references therein). Loss of p53 function, as occurs frequently in human cancer cells, leads to decreased DNA repair of these types of lesions, and in some cell types, this is reflected by increased cellular sensitivity to these agents (7, 9, 13, 16, 20, 39-41).
An important question concerning the connection between p53 and NER is
to what extent the p53 protein participates directly in DNA repair
(28, 48), versus p53 transcriptionally regulated gene
products that contribute to the NER response. For example, p53 has been
shown to directly associate with TFIIH, an NER component (28,
48), while genes implicated in repair, such as DDB2
(23, 24) and gadd45, are p53 regulated (24,
25). In addition, gadd45 is UV responsive, even in
p53-deficient cells (51). In the case of gadd45,
its protein product is known to associate with proliferating cell
nuclear antigen (PCNA), core histones, p21, and MTK1 (6, 27, 38,
45, 47), and reduced repair, as measured by host cell
reactivation of UV-damaged plasmid reporter, was observed in RKO cells
expressing antisense Gadd45 (40). However, the
conclusion that Gadd45 contributes to NER is complicated by
several issues. First, the antisense approach only suppressed Gadd45
expression, but did not ablate it. Second, the study was carried out
with a human tumor line that contained additional genetic changes.
Third, one such mutation resulted in the mismatch repair-deficient
phenotype, and mismatch repair has been implicated in damage
recognition (32). Moreover, RKO cells express higher levels
of Gadd45 than are observed for most human cell lines (40). Here we have used mouse embryo fibroblasts (MEFs) carrying
homozygous deletions of the p53 gene or deletions of known
component genes (downstream effectors) of the p53 pathway
p21 (Cdkn1a, also known as cip1,
waf1, or sdi1) and gadd45
(Gadd45a, also known as Gadd45
) or MEFs
lacking both gadd45 and p21
(gadd45/p21-null cells). The present study is the first to
explore the components of the p53 pathway that contribute to DNA repair
in an isogenic, primary cell system carrying only the defined
genetic alterations. Rodent cells do, however, exhibit intrinsically
slower global genomic repair (GGR) of cyclobutane pyrimidine
dimers (CPDs) than human cells (14).
Recent studies using gadd45-null cells showed that Gadd45
contributes to maintenance of genomic stability, inasmuch as cells lacking gadd45 genes exhibited multiple chromosome
abnormalities, and gadd45-deficient mice showed increased
radiation carcinogenesis (22). While perturbation in
the control of G2 cell cycle progression was
also observed, control of G1 checkpoints after either
ionizing radiation (IR) or UV radiation as well as radiation-induced
apoptosis was equivalent in gadd45
/
and
wild-type cells (22). Although the components of the p53 pathway involved in apoptosis and cell cycle checkpoint control are
well known, much less is known about p53 and the roles of its
downstream effectors in the maintenance of genomic stability, including
DNA repair. For example, p53 mutants have been isolated from human
cancers that retain the apoptotic and cell cycle arrest properties of
wild-type p53, but are nonetheless associated with genomic instability
and carcinogenesis (43).
Two approaches were used to assess acute responses to UV irradiation in
the MEF lines, measurements of DNA repair synthesis as unscheduled DNA
synthesis (UDS) after UV irradiation and quantification of major
photoproducts remaining at various times after UV irradiation. Long-term cytotoxicity responses in these cell lines after treatment with UV radiation or cisplatin suggest that p53-downstream
effectors
Gadd45 in particular
contribute to NER responses and may
influence cellular sensitivity to certain DNA-damaging agents.
A potential mechanism by which Gadd45 might interact with cellular NER was suggested by a recent study showing that Gadd45 interacts with chromatin (6). In this study, Gadd45 was found to have some similarity to other acidic chromatin-interacting proteins and was found to bind to UV-irradiated nucleosomes. Gadd45 also disrupted histone DNA associations in vitro (6). We now present evidence that Gadd45, in the presence of other nuclear factors, affects chromatin remodelling of damaged plasmid templates concurrent with DNA repair in vitro.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
MEFs.
Mouse embryos at 13.5 days of gestation were isolated
in utero and cells were dispersed by using a razor blade. Resultant cells were cultured overnight, and were frozen as soon as was practical. MEFs from matched littermates were screened for the presence
or absence of the appropriate gene sequences by Southern blotting
and/or by PCR for the presence of diagnostic restriction fragments.
MEFs lacking p53 genes were from previously published studies (25). The generation of mice lacking p21
genes has been described previously (8). Mice hemizygous for
the presence or absence of p21 genes were bred to generate
matched sets of p21+/+ and
p21
/
MEFs. The construction of
gadd45
/
and gadd45/p21-null mice
has been reported elsewhere (22). The gadd45 gene
disruption ablates all but 37 carboxy-terminal residues of the expected
protein product and all of the essential promoter region. As controls
in the UDS studies, we used the rb
/
MEFs
(kindly provided by Allan Bradley, Baylor College of Medicine or
p16ink4a
/
MEFs (kindly provided by Ronald
DePinho, Dana-Farber Cancer Center). Cells were stored in liquid
nitrogen, and upon thawing, were used within one to three passages.
Results were obtained from two p53
/
MEF
lines, three gadd45
/
lines, and two
p21
/
lines. Only one MEF line was available
carrying the gadd45/p21-null genotype. MEFs from matched
littermates were used whenever possible.
UDS technique.
UDS assays were carried out essentially as
described previously (40). Primary MEFs grown on glass
slides were transferred to 150-mm2 dishes, and each
respective nullizygous MEF line was irradiated side-by-side with
corresponding wild-type (+/+) controls. Cells were irradiated with 20 J of UV radiation m
2 (254 nm) and were incubated for
3 h in serum-free medium containing [3H]thymidine
(10 µCi per ml). Experiments with lower doses yielded similar
results, but fewer tritium grains. Alternatively, cells were exposed to
100 µM cisplatin for 5 h concurrent with
[3H]thymidine uptake. Cells were processed for
autoradiography, and nuclei were photographed by using a ×100
objective (Olympus model AX70) under oil-immersion optics. The number
of tritium grains per nucleus was determined from the photomicrographs
by using a manual colony counter. Negative controls consisted of unirradiated MEFs, and the human xeroderma pigmentosum XP-A cell line
XP12BE (40).
PCNA immunostaining.
Cells were grown on glass slides and
irradiated with 20 J of UV radiation m
2 as for UDS
studies. After 1.5, 3, or 6 h, slides were incubated in the
presence of 1% Triton X-100 and methanol fixed. PCNA was detected with
antibody PC10 (Oncogene Science, Inc.) followed by
fluorescein-conjugated goat anti-mouse immunoglobulin G (Sigma).
Global genomic NER assay.
The relative number of UV-induced
photoproducts, and 6-4 pyrimidine-pyrimidone photoproducts (6-4 pps) in
total unreplicated genomic DNA from cells collected at various times
following UV irradiation was determined using an immunoblot assay, as
previously described (12). Briefly, exponentially growing
cells were labeled with [3H]thymidine, washed with
phosphate-buffered saline, and irradiated with 10 J of UV
m
2 using a 15-W germicidal UV lamp delivering
predominantly 254-nm light. Cells were either lysed immediately for an
initial sample or were incubated in growth medium containing
5-bromodeoxyuridine (BrdU) to density label newly replicated DNA and
then lysed at various times. Density labelling was performed during
repair periods to allow unreplicated DNA to be isolated by cesium
chloride isopycnic density gradient sedimentation. Equal amounts from
each DNA sample were fixed to a Hybond N+ nylon membrane (Amersham) in
triplicate by using a slot-blot apparatus. The membrane was incubated
with mouse monoclonal antibodies specific for either CPDs or 6-4 pps (34) and horseradish peroxidase-conjugated secondary
antibody. Enhanced chemiluminescence (Amersham) and phosphorimager
analysis (Bio-Rad model GS-363) were employed for detecting the primary antibodies. Following antibody detection, equal DNA loading to each
slot of the membrane was confirmed by scintillation spectrophotometry of the 3H-DNA on individual pieces cut from the membrane.
Strand-specific repair assays.
The rates of photoproduct
removal were determined within the transcribed (TS) and nontranscribed
(NTS) strand of a 14-kbp BamHI restriction fragment spanning
the central region of the mouse dhfr gene, as described
previously (36). Cells were irradiated with 10 Jm
2 of UV radiation, lysed immediately for an initial
sample, or incubated for the times indicated to allow photoproduct
repair. The frequency of induction and rate of removal of CPDs from TS and NTS of the dhfr gene was measured by treating purified
BamHI-digested DNA with T4 endonuclease V (TEV), and then
quantifying the reappearance of the full-length restriction fragments
in DNA from cells allowed various times to remove the lesions.
BamHI-treated samples from each time point were treated or
mock treated with TEV, electrophoresed in parallel under denaturing
conditions, Southern-transferred to a membrane, and then hybridized to
strand-specific RNA probes generated by in vitro transcription. The
ratio of full-length restriction fragments in the TEV-treated and
untreated samples was determined by phosphorimager analysis and was
used to calculate the average number of TEV-sensitive sites (unrepaired
lesions) per fragment by using the Poisson distribution
(12).
Survival responses to UV irradiation or cisplatin. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assays were carried out as described previously (10), but were terminated at 7 days. For cisplatin, cells were treated in microtiter wells for 72 h (40). For UV radiation experiments, cells were irradiated in 60-cm2 dishes and were dispensed in microtiter plates for quantitation on day 7. Assays were quantified by the use of a microtiter plate reader (E-max; Molecular Devices, Inc.). All survival data are expressed relative to untreated cells in the same experiment, as previously described (10).
Clonogenic survival experiments were conducted as described previously (38-40), except that irradiated feeder layers were used to alleviate the poor plating efficiency of MEFs. p53-null MEFs were used as feeder cells and were irradiated with 100 Gy of ionizing radiation. Approximately 5 × 105 feeder cells were applied per 10-cm2 dish. Each respective MEF line was then plated on the feeder layer and treated with DNA-damaging agents (UV radiation or cisplatin). Some experiments were also performed without feeder layers. While irradiated feeder cells did not grow, colonies (>100 cells/colony) of each respective MEF line were visible after 12 days and were counted by a manual colony counter as described previously (38-40).Cell cycle analysis.
Wild-type or
gadd45
/
MEFs were prepared for
fluorescence-activated cell sorter (FACS) analysis as described
previously (9, 10). Cells were arrested in G0 by
serum deprivation and irradiated with 10 J of UV radiation
m
2 (254 nm) and were incubated in complete medium
containing 10 µM BrdU for 24 h. BrdU incorporation was detected
by an anti-BrdU fluoroscein-conjugated antibody (Becton-Dickinson)
(10). Propidium iodide (PI) staining for DNA content was as
previously described (9, 10). Cell cycle analysis was
performed using a Becton-Dickinson FACScan flow cytometer. The
Cell-Quest software package (Becton-Dickinson) was used to
analyze the data in which 15,000 BrdU-positive cells were analyzed in
each individual sample. All available evidence from other studies
showed a lack of effect of gadd45 deficiency on the first
G1 (nor the second G1) arrest after DNA damage
(29, 49). Attention was therefore focused on S and
G2/M phases by the gating of BrdU-labeled cells. Only
actively cycling cells are counted by this technique.
/
MEFs were irradiated with 10 J of UV radiation m
2, incubated for 15 h in
complete medium, and then labeled for 3 h with
[3H]thymidine. Autoradiography was conducted as for UDS
experiments. Although UDS was not detected after 15 h (i.e., most
of the UDS occurs within the first few hours), the percentage of
S-phase cells 15 h after UV irradiation was determined from
photographic fields similar to those shown in Fig.
1A.
|
In vitro NER-chromatin assembly assay.
Whole-cell extracts
(WCE) and nuclear (NUC) extracts were prepared from stimulated, growing
wild-type or gadd45
/
mouse lymphoblasts
(22). Assays were conducted in the presence of 100 µg of
WCE and 50 µg of NUC extracts, utilizing a UV-damaged plasmid
template (>20 lesions per plasmid molecule [38, 39]). WCE are fully competent for NER, while NUC extracts provide chromatin assembly factors and DNA topoisomerases as described previously (15). Assays were carried out in 50-µl reaction mixtures
as described previously (38, 39). Approximately 150 fmol of
radioactive nucleotide was incorporated during repair synthesis and
subsequent steps, as determined by phosphorimager quantitation.
Recombinant Gadd45 (human; rGadd45) was added to gadd45-null
extracts to result in increased recovery of repaired (labeled by
32P) and subsequently remodeled (supercoiled and assembled
into nucleosomes) plasmid template. rGadd45 was highly purified by high-pressure liquid chromatography (6) (a gift from F. Carrier, University of Maryland). For micrococcal nuclease (MNase)
studies, in vitro reactions were conducted in parallel to those above, except that 32P-dCTP was omitted. MNase (0.001 U) (Sigma)
was added directly to the reaction mixtures, incubated for an
additional 5 min, and terminated by phenol-chloroform extraction, and
ethanol precipitation.
| |
RESULTS |
|---|
|
|
|---|
Measurements of DNA repair synthesis in situ by UDS technique.
DNA repair synthesis in UV-irradiated MEFs was quantified by
unscheduled DNA synthesis (UDS; see Materials and Methods). UDS relies
on the ability to distinquish replicative DNA synthesis from repair
synthesis. Cells in S phase at the time of irradiation exhibit dense
nuclear labelling (Fig. 1A). Cells that traverse the G1/S
boundary during the 3-h labelling period exhibit a characteristic pattern of "replicon initiation" synthesis (Fig. 1B). The
G1 phase of the cell cycle is 15 to 16 h in MEFs
(21), while the duration of the UDS experiments is 3 h.
Therefore, although MEFs spend a majority of the time in
G1, few cells would traverse the G1/S boundary
during this type of experiment. Repair synthesis (UDS) was detected in
all non-S phase, and non-G1/S transitional cells, irrespective of whether cells were in G1 or in
G2 (Fig. 1B). NER-defective XP12BE cells showed little or
no UDS (results not shown and reference 40). In
NER-competent cells, the number of grains per nucleus is a direct
measure of the number of sites of DNA repair synthesis per nucleus and
is linear with UV dose (2, 5, 14, 40). When the wild-type
and mutant MEFs were compared, there was a clear difference in the
number of grains per nucleus (Fig. 1B). We assayed only G1
nuclei in the current study for purposes of consistency; i.e.,
G2 nuclei were assayed in separate experiments but yielded
results similar to those shown for G1 nuclei
(G2 results not shown). A number of independent experiments
were conducted for each respective pair of wild-type and mutant MEF
lines (in total, eight experiments were conducted for
p53
/
; four experiments for
p21
/
, five experiments for
gadd45
/
, and eight experiments for
gadd45/p21-null MEFs). As negative controls, two experiments
each were conducted in rb
/
and
p16
/
MEFs. The data from all of these
experiments (average relative number of grains per nucleus) are
summarized in Fig. 1C to E.
/
MEFs
exhibited 35 to 70% of the normal UDS in response to UV irradiation,
in agreement with other experimental approaches in which NER was found
to be decreased in cells lacking functional p53 (11-13, 39,
40). Importantly, gadd45
/
MEFs
exhibited UDS that was 61 to 71% of the wild-type level (P < 0.0001 by Student t test), while the UV-induced UDS
response of gadd45/p21-null MEFs was 23 to 55% of the
wild-type level (P < 0.0001 by Student t
test) (Fig. 1C). An additional series of experiments utilized cisplatin
as a DNA-damaging agent (Fig. 1E). In these experiments, the UDS
response to cisplatin treatment in p53
/
MEFs
was 25 to 50% of wild-type, while gadd45/p21-null MEFs
showed 25 to 35% UDS compared to the wild type (P < 0.0001 by Student t test) (Fig. 1E).
Included in some studies, as controls, were MEFs lacking rb
or p16ink4a tumor suppressor genes (see Materials and
Methods for details). Neither rb
/
nor
p16ink4a
/
MEFs exhibited an NER defect as
measured by UDS (Fig. 1D), although they did exhibit deregulated cell
cycle regulation. Therefore, reduced (UDS) labelling in
G1 (observed in p53
/
and
gadd45
/
MEF lines) is not due to accelerated
S-phase entry. Indeed, p16
/
MEFs exhibited a
very high S-phase fraction (approximately 50%; results not shown), yet
showed normal repair measured as UDS (Fig. 1D). UDS studies with
serum-starved (G0) wild-type or
p53
/
MEFs yielded similar results (not
shown), which indicated that the NER defect associated with p53 occurs
even in noncycling cells. Because replicative DNA synthesis and repair
synthesis are two distinct processes (Fig. 1B), the S-phase fraction of
a given cell line does not appear to be relevant to UDS. Analysis of
UDS data was confined to 2N (G1) nuclei merely for purposes
of consistency. There is evidence that NER does not differ between
G1 and G2 cells (33
[discussed in reference 41]). Moreover,
p53
/
MEFs that were synchronized or arrested
in G2 also exhibited reduced UDS (results not shown).
PCNA is recruited to sites of DNA damage, and PCNA immunostaining may
be used to reflect DNA repair responses (2). PCNA immunostaining was reduced in gadd45-null MEFs, which is
consistent with the UDS results (Fig. 1F). In the absence of DNA
damage, there appeared to be no differences in PCNA expression between the two cell lines, as measured by Western blotting (results not shown).
Repair of CPDs and 6-4 pps in global genomic DNA.
Experiments
were performed to measure specifically the removal of the major
UV-induced photoproducts CPDs or 6-4 pyrimidine-pyrimidone photoproducts (6-4 pps) from global genomic DNA by using an immunoblot assay with monoclonal antibodies to each of these photoproducts. The
repair of 6-4 pps from global genomic DNA showed substantial differences between the different MEF lines, as shown in Fig. 2A. Wild-type MEFs demonstrated efficient
removal of 6-4 pps, with 63% of the lesions repaired by 4 h and
75% of the lesions repaired by 8 h after UV irradiation. (The
level of photoproducts in unirradiated cells is designated as 100%
removal or repair.) p53-deficient MEFs exhibited a defect in repair of
6-4 pps, as well as CPDs (36), in line with previous studies
conducted with human cells (11-13). Note that
gadd45
/
and gadd45/p21-null MEFs
exhibited the greatest defect, with only 18 to 27% of the lesions
being repaired even after 24 h while p21
/
MEFs showed essentially normal repair
of 6-4 pps after 24 h (Fig. 2A).
|
Strand-specific repair assays.
Quantitative Southern blotting
of TEV-treated DNA from UV-irradiated cells was used to examine CPD
removal from TS and NTS strands of the dhfr gene. Previous
studies of p53-deficient human cells showed that p53 deficiency did not
significantly affect repair of the dhfr TS (repaired by
TCR), but did markedly affect repair of the NTS (11-13)
(repaired by GGR). Similar to p53-deficient human cells, MEFs lacking
p53 or gadd45 genes exhibited nearly normal TCR
of the transcribed strand of the dhfr gene, but defective GGR of the NTS of the dhfr gene (Fig. 2B). Importantly,
p21
/
cells exhibited nearly normal levels of
repair of either strand (Fig. 2B) (J. M. Ford, unpublished data).
Cellular sensitivity to UV irradiation or cisplatin.
In some
cell types, loss of p53 function and the corresponding decrease in NER
capacity sensitize cells to agents that produce DNA damage that is
repaired by NER (7, 9, 10, 13, 16, 20, 39, 40). These agents
include, in addition to UV irradiation, many chemical cross-linking
agents, such as cisplatin or nitrogen mustards. We tested
p53
/
, p21
/
,
gadd45
/
, and gadd45/p21-null MEFs
for sensitivity to some of these agents by using 7-day MTT (thiazolyl
blue) cell survival assays. Each of the mutant MEF lines
displayed enhanced sensitivity to UV radiation or cisplatin compared to
wild-type MEFs (Table 1). Similar results were obtained using melphalan (a nitrogen mustard; results not shown).
Table 1 shows 50% inhibitory concentration (IC50)
data, which is the dose or concentration of a given agent required to give 50% survival, for each MEF line.
|
2 demonstrated a mean surviving fraction of 65% for
wild-type cells and only 25% for gadd45/p21-null cells.
After 20 J of UV radiation m
2, wild-type cells
exhibited 51% mean survival, compared to only 9% for
gadd45/p21-null cells. Cisplatin yielded similar results (not shown). Thus, the mutant MEFs were more sensitive to UV radiation and cisplatin than the wild type, as determined by both types of
assays, consistent with other reports (16, 20). There were, however, differences in the actual doses of DNA-damaging agents required, between the two types of survival assays, owing perhaps to
differences in cell density, e.g., the presence or absence of feeder
cells. (Higher doses of DNA damage were required to achieve equivalent
cell killing in the presence of feeder layers, probably because feeder
cells secrete cytokines that promote cell survival.)
Reduced S-phase progression in gadd45-null cells after
UV radiation.
The results shown in Fig. 1 and 2 provided strong
evidence that Gadd45 is one component of the p53 pathway that
contributes to DNA repair. In the present study, absence of Gadd45
resulted in the persistence of photolesions (Fig. 2), lesions that are known to interfere with replicative DNA synthesis. While
gadd45
/
cells have already been shown to
have normal p53-mediated G1 checkpoints after IR or UV
radiation (22), we focused on S-phase progression by
employing FACS analyses of MEFs in the presence or absence of UV
damage. The data are summarized in Fig.
3A and B. Cell cycle profiles of
wild-type and gadd45
/
cells were similar in
the absence of DNA damage and indicated that the cells were actively
growing. However, after UV irradiation, a pronounced S-phase
accumulation of gadd45
/
cells was observed.
This result is similar to those reported by other groups regarding
UV-irradiated p53-deficient cells (7, 10, 20) and
is consistent with defective NER and subsequent replicative arrest. We
also determined the S-phase fractions 15 h after UV irradiation by
[3H]thymidine labeling. Consistent with the FACS
analysis, gadd45
/
MEFs exhibited a
pronounced S-phase fraction 15 h after UV (Fig. 3C). Thus,
gadd45
/
MEFs exhibit an S-phase delay after
UV irradiation, due perhaps to persistence of UV photoproducts (Fig.
2), consistent with a slow DNA repair phenotype resulting in inhibition
of DNA replication at damaged sites (Fig. 3).
|
Biochemical NER assays to explore Gadd45 function(s).
The core
NER reaction can be carried out in vitro in the presence of WCE
(1, 37). However, WCE extracts may be relatively depleted of
a number of nuclear proteins including DNA topoisomerases and chromatin
remodeling factors, that while not required, may contribute to NER
(14, 15, 50). The contributions of nuclear proteins to in
vitro NER reactions, can be assessed by the addition of nuclear
fractions (NUC) to WCE-NER reaction mixtures (15). By this
approach, chromatin assembly and disassembly have been identified as
processes closely linked to NER (15, 18, 23, 26, 50). WCE
and NUC extracts were prepared from mouse lymphoblasts derived
from either wild-type or gadd45
/
animals. The presence of Gadd45, either as an endogenous component of
NUC extracts from wild-type mouse cells or added exogenously to
gadd45
/
extracts, promoted chromatin
assembly on plasmids undergoing or having undergone NER in vitro,
although the amount of recombinant Gadd45 (400 ng) exceeded the amount
endogenous to wild-type extracts (20 to 50 ng). Ethidium bromide (EtBr)
staining was used to show approximate equal loading of the lanes, while
repair synthesis was measured by 32P incorporation (panels
marked 32P) into the damaged plasmids. Note that while very
little form I DNA was recovered from the reactions (total plasmid DNA
shown by EtBr staining), an appreciable amount of radiolabeled
(repaired) plasmid DNA was recovered as form I DNA; i.e.,
repaired plasmids were preferentially assembled into nucleosome
ladders, which showed a characteristic MNase digestion pattern (Fig.
4B). Recovery of (repaired) form I
DNA was enhanced in the presence of Gadd45 (Fig. 4A). The chromatin
remodeling reaction could not be uncoupled from the NER reaction
(reference 15 and results not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
Effect of p53 pathway on the GGR subpathway of NER. NER can be classified into two broad subpathways: TCR and GGR. Recent studies show that p53 affects primarily GGR (11-13), although one study suggested a contribution of p53 to TCR in addition to GGR (46). In the present study, we examined both GGR and TCR, and as shown previously in human cells lacking p53 function, GGR was markedly affected. Defective GGR repair of 6-4 pps was more pronounced in the gadd45-deficient MEFs than in the p53-deficient MEFs (Fig. 2A), suggesting that Gadd45, like p48-XPE (DDB2, the p48 DNA-damage-binding protein that is defective in a subset of xeroderma pigmentosum group E patients [24]) contributes considerably to the p53-mediated NER response. The contributions of p53-regulated genes Gadd45 and p48-XPE to DNA repair responses define a new paradigm of p53 function, separable from other known p53 functions in cell cycle arrest and apoptosis. While p21 is a major mediator of p53-mediated G1 cell cycle arrest, p21 contributes relatively little to DNA repair at early times (3- to 4-h time points in Fig. 1 and 2), and not at all at later time points (24 h; Fig. 2A). On the other hand, approximately 50% of the 6-4 lesions persist in the gadd45-deficient cells even after 24 h (Fig. 2A). We also assayed strand-specific repair of TS and NTS strands of the dhfr gene by using TEV assays. MEFs lacking p53 or gadd45 genes exhibited defective CPD repair of the NTS, but near normal TCR of the TS (Fig. 2B). Thus, a pronounced GGR defect associated with p53 or gadd45 loss is clearly shown by both types of assays.
Relationship of p53-mediated NER to G1 checkpoint and p21. The p53-mediated NER response appears to be distinct from the G1 cell cycle checkpoint, as indicated by several lines of evidence: Li-Fraumeni fibroblasts heterozygous for mutant or wild-type p53 genes retain the G1 checkpoint, but nonetheless exhibit an NER defect (11); HPV16-E7 oncoprotein expression, which blocks Rb, and hence blocks G1 cell cycle arrest, had no effect on NER (40). In the present study, rb- or p16-null MEFs exhibited altered G1 cell cycle control, but not altered NER, while gadd45-null MEFs showed no G1 checkpoint abnormality (22), but deficient NER (Fig. 1). Although the UDS experiments measured NER primarily in G1 nuclei, these could be readily distinguished from G1/S transitional nuclei (Fig. 1B), and, moreover, p53-null cells synchronized or arrested in G1 or G2 also showed an NER defect (results not shown). Although p21 is a major mediator of p53-induced G1 arrest, p21-null MEFs exhibited only a very slight NER defect (discussed below), contrary to what one would predict were the NER defect dependent on or coincident with the G1 checkpoint.
The potential contribution of p21 to DNA repair has been unclear. Some studies have shown reduced capacity for NER and UV sensitivity in p21-null HCT116 cells (31). In the present study, a modest but statistically significant decrease in UDS (75% of the wild-type level) was observed in p21
/
MEFs
3 h after UV irradiation, and gadd45/p21-null MEFs
exhibited a greater defect than either of the single nullizygous
mutants, which was again statistically significant. Indeed,
p21 and gadd45 appear to be "additive" in
their effects on NER measurements taken 3 h after irradiation
(Fig. 1C), an interesting and novel observation that could possibly be
due to subtle cell cycle differences, with due consideration of the
caveats mentioned in the preceding paragraph. The 6-4 pp removal
experiments are consistent with the UDS results (3 to 4 h after UV
irradiation), but these experiments also showed that
p21
/
cells recovered normal levels of NER
after 24 h (Fig. 2A). TEV assays likewise showed essentially no
effect of p21 deficiency on NER 24 h after UV irradiation (Fig.
2B). Thus, the effect of p21 on NER appears to be minimal, and Gadd45
contributes considerably to the p53-mediated NER response. Note that at
the 3-h time point, where greater than 50% of the 6-4 pps lesions are
removed from genomic DNA of wild-type cells, only 15% of the lesions
were removed in gadd45
/
cells. After 24 h, wild-type and p21
/
cells were essentially
identical in 6-4 lesion repair, while gadd45
/
cells still retained about 50% of
the 6-4 lesions (Fig. 2A).
If p21 does contribute, albeit minimally, to NER, as suggested by Fig.
1, it is likely that this function is unrelated to p21 activity as a
cyclin-dependent kinase inhibitor, because, again, neither HPV16-E7
expression, nor rb or p16 deficiency
recapitulates the effect of p53 or gadd45
deficiency on NER. Moreover, it is conceivable that any effect of p21
on NER may require the presence of additional genetic alterations, such
as mutS deficiency in HCT116 cells or gadd45
deficiency in the gadd45/p21-null MEFs. The complex
relationship of p53-mediated DNA repair to the activation of cell cycle
checkpoint(s) will be the subject of future studies.
Cell cycle checkpoint responses to UV radiation may differ from the
well-known G1 checkpoint response elicited by IR (and also
G1 arrest by UV radiation to some extent [25,
51]) and mediated by cyclin-dependent kinase inhibitor p21. In
contrast, p53-mediated responses to UV radiation can involve the S
phase and G2/M delays, which may reflect the greater lesion
frequency of UV photoproducts compared to IR-induced damages. The cell
cycle analyses in Fig. 3 further dissociate the p53/gadd45-mediated response to UV radiation from the p53/p21-mediated response to IR, in
that the presence or absence of Gadd45 showed no effect on
G1 arrest in the present and previous experiments
(reference 22 and results not shown), and in fact,
the experiments in Fig. 3A and B, employing BrdU incorporation, were
specifically designed to exclude cells arrested in the first
G1 phase from the analysis.
Gadd45-deficient cells exhibit slow repair. It should be noted that p53 protein and a number of downstream effector proteins are present at appreciable basal levels in many cell types, including normal human and mouse fibroblasts (7). This has also been observed for the p48-XPE gene product. p48-XPE is expressed at higher basal levels in p53 wild-type cells than p53 mutant cells, but is induced after DNA damage only in p53 wild-type cells (24). This may explain why DNA repair functions are significantly enhanced in p53-wild-type cells at early times (3 to 4 h after UV irradiation; Fig. 1 and 2). On the other hand, MEFs nullizygous for gadd45 genes did not achieve normal levels of 6-4 pp repair even after 24 h (Fig. 2A). TEV assays likewise showed a pronounced NER deficiency in gadd45-null cells (Fig. 2B). The persistence of lesions in gadd45-deficient cells led to S-phase delay 24 h after UV irradiation (Fig. 3). S-phase delay may represent an active checkpoint response or may reflect a blockage of replication fork progression at UV-induced lesions, as observed in other NER-defective cells (17). The cell cycle results shown in Fig. 3 are consistent with an NER defect causing replicon stalling at damaged nucleotide bases (17). Persistence of lesions (e.g., after 24 h as shown in Fig. 2) may continue to trigger cell cycle checkpoint responses, including p53, although gadd45 deficiency produced no overt changes in p53 or p21 mRNA or protein expression at early times (3 to 12 h) following DNA damage (results not shown).
Cytotoxic responses to DNA-damaging agents.
In this study and
others, cells lacking p53 or components of the p53 pathway were
sensitized to UV- or cisplatin-induced DNA damage (previously cited).
These findings provide a counterpoint to the prevalent view that cells
lacking functional p53 are often desensitized to DNA damage (attributed
to escape from apoptosis). There are a number of implications that
follow. (i) Many epithelial cell types may die by mechanisms other than
apoptosis, e.g., cytotoxicity of DNA damage (3). (ii) In
these cell types, loss of functional p53 either has no effect on cell
death responses, or in the case of UV or cisplatin damage, can result
in enhanced cell death. (iii) Downstream effectors of the p53 pathway
can contribute to cell survival responses, although DNA repair is only
one of multiple parameters that influence cytotoxic responses to DNA
damage. For example, p21
/
cells also were
more sensitive to UV radiation, due probably to G1
checkpoint loss. It will be of interest to explore further the role of
p53 in cell death or survival responses in epithelial and other cell
types in which p53 activation is associated with DNA repair (survival)
responses rather than apoptosis.
Coupling of later stages of NER to chromatin assembly. The mechanism of NER consists of several steps including incision of the DNA strand carrying the damage, displacement of an approximately 30-nucleotide oligomer containing the damaged base(s), resynthesis of the correct sequence using the complementary strand as a template, and ligation. Because mammalian cells package their genomes into chromatin, one may also consider that destabilization of the preexisting chromatin structure may affect early phases of NER, inasmuch as nucleosomes may impede NER (14). One may also consider that restoration of chromatin structure, i.e., repositioning of nucleosomes along newly repaired DNA, would be required to maintain proper regulation of genomic functions. In fact, other studies have shown that the NER process is tightly linked to chromatin assembly (15). Specifically, the passage of the DNA polymerase associated with repair synthesis was found to promote chromatin formation. This was demonstrated by the finding that plasmid templates undergoing NER in vitro were preferentially assembled into nucleosomes (over those that were not repaired, and therefore retain DNA damage). Stated another way, this means that the repair process promotes nucleosome assembly when all factors are available. The chromatin assembly factor CAF1 was implicated as a mediator of the chromatin remodelling process, because nuclear extracts containing CAF1 could carry out the nucleosome assembly step, while CAF1-deficient extracts could not (15). Moreover, the chromatin assembly step could not be uncoupled from NER, because plasmids that were repaired in WCE extracts, recovered by extraction and ethanol precipitation, and then subsequently incubated with nuclear extracts did not exhibit nucleosome assembly (15). These findings implicated CAF1 in a late step of NER, in which repaired DNA is then repackaged into a native configuration. Supercoiled plasmids were consequently recovered from in vitro repair reactions (15). We show evidence that Gadd45 participates in late-stage NER steps involving chromatin assembly. As mentioned above, nucleosome assembly is inhibited by DNA damage, particularly in the form of bulky lesions or UV damage which may cause helical distortions. It is clear from Fig. 4 that Gadd45 promotes one or more activities associated with this process.
p53-regulated gene products involved in chromatin accessibility. A recent study showed that Gadd45 binds to UV-damaged chromatin and may affect accessibility to sites of DNA damage (6). A number of reports in the literature suggest that chromatin accessibility proteins such as yeast and human CAF-1 (mentioned above and in references 15 and 26), and Saccharomyces RAD7 and RAD16 (50), while not components of the core NER complex, can specifically contribute to the GGR subpathway of NER. XPC, which is also required for normal GGR (44), has also been implicated in damage recognition which could involve either DNA damage or chromatin damage (3, 44). Such a role for Gadd45 would be consistent with the present results, wherein MEFs lacking gadd45 exhibit defective GGR. An additional link between p53 and the GGR subpathway of NER is suggested by the finding that the xeroderma pigmentosum group E (XP-E) p48 gene, like gadd45, is transcriptionally regulated by p53 (24). The NER defect in XP-E likewise affects the GGR subpathway (23, 24). Interestingly, the p48-XPE protein shares sequence homology with CAF-1 (23), while Gadd45 shares some homology to other chromatin accessibility proteins (6).
One means by which chromatin accessibility factors may contribute to NER is by facilitating the binding of damage recognition proteins and/or other proteins involved in DNA damage processing, to sites of DNA damage. One such protein, PCNA, is known to bind strongly to damaged chromatin after UV irradiation. The binding of PCNA to damaged chromatin is defective in XP cells, strongly suggesting that the "recruitment" of PCNA to damaged chromatin reflects its involvement in NER (determined by immunostaining of Triton-resistant PCNA [2]). In the present study, PCNA immunostaining after UV radiation was defective in Gadd45-deficient cells (Fig. 1F). This finding suggests that PCNA may be one such protein whose interaction with damage sites is affected by the presence or absence of Gadd45 (2), which interestingly has been shown to associate with PCNA (19, 38, 47). Since naked plasmid DNA was introduced to the in vitro DNA repair reactions (Fig. 4), the assay may not address early events involving recognition of damaged DNA in chromatin. However, the present results clearly illustrate a role for Gadd45 in chromatin assembly. A possible role for Gadd45 in chromatin accessibility early in the reaction cannot be excluded. Indeed, the RAD7 and RAD16 proteins, previously shown to be chromatin accessibility factors, that enhanced NER, but were not required for NER (50), have more recently been shown to act as a part of a DNA damage sensor mechanism, by binding to UV-damaged chromatin as a component of the damage recognition step (18). One implication is that Gadd45 signalling may participate in DNA damage responses, at least in some cases, upstream of p53 in the damage-response pathway (49), as would be predicted were Gadd45 to play a role in damage recognition. Such a postulated role for Gadd45 early in the repair reaction would be consistent with the UDS experiments, in which gadd45-deficient cells exhibited a defect in the repair synthesis step of NER (Fig. 1), but could also be due to the temporal coupling of repair synthesis with latter-stage chromatin remodeling (Fig. 4) (15). In summary, we have used a genetic approach to dissect components of the p53 pathway that contribute to DNA repair responses. In particular, Gadd45 contributes appreciably to DNA repair, while p21 contributes relatively little. One interpretation is that p53-associated NER may be independent of the G1 cell cycle checkpoint mediated by p21 (25). Recent studies showed that Gadd45 binds to UV-damaged chromatin, perhaps facilitating access to regions of DNA damage (6). The p53-associated NER response may therefore be mediated at the level of chromatin accessibility to sites of DNA damage.| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by Clinical Investigator Award KO8-CA64330 (J.M.F.) and Outstanding Investigator grant CA44349 (P.C.H.), both from the National Cancer Institute; and by grant 1RG84-002-15 from the American Cancer Society (M.L.S.). We thank Jay Robbins for helpful advice on UDS experiments and Rodney S. Nairn, Maureen A. Harrington, Rick Bockrath, and members of the Fornace and Hanawalt laboratories for critical comments on the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Indiana University Cancer Center, Department of Microbiology and Walther Oncology Center, R4-155, Indiana University School of Medicine, Indianapolis, IN 46202.
Present address: Departments of Medicine and Genetics, Division of
Oncology, Stanford University School of Medicine, Stanford, CA 94305.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aboussekhra, A., M. Biggerstaff, M. Shivji, J. Vilpo, V. Moncollin, V. Podust, M. Protic, U. Hubscher, J.-M. Egly, and R. D. Wood. 1995. Mammalian DNA excision repair reconstituted with purified protein components. Cell 80:859-868[CrossRef][Medline]. |
| 2. | Aboussekhra, A., and R. D. Wood. 1995. Detection of nucleotide excision repair incisions in human fibroblasts by immunostaining for PCNA. Exp. Cell Res. 221:326-332[CrossRef][Medline]. |
| 3. |
Baxter, B. K., and M. J. Smerdon.
1998.
Nucleosome unfolding during DNA repair in normal and xeroderma pigmentosum (group C) human cells.
J. Biol. Chem.
273:17517-17524 |
| 4. |
Brown, J. M., and B. G. Wouters.
1999.
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Cancer Res.
59:1391-1399 |
| 5. | Burk, P. G., M. A. Lutzner, D. D. Clarke, and J. H. Robbins. 1971. Ultraviolet-stimulated thymidine incorporation in xeroderma pigmentosum lymphoblasts. J. Lab. Clin. Med. 77:759-767[Medline]. |
| 6. |
Carrier, F.,
P. T. Georgel,
P. Pourquier,
M. Blake,
H. U. Kontny,
M. J. Antinore,
M. Gariboldi,
T. G. Myers,
J. N. Weinstein,
Y. Pommier, and A. J. Fornace, Jr.
1999.
Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin.
Mol. Cell. Biol.
19:1673-1685 |
| 7. |
Cistulli, C. A., and W. K. Kaufman.
1998.
P53-dependent signalling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
Cancer Res.
58:1993-2002 |
| 8. | Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684[CrossRef][Medline]. |
| 9. |
Fan, S.,
M. L. Smith,
D. J. Rivet,
D. Duba,
Q. Zhan,
K. W. Kohn,
A. J. Fornace, Jr., and P. M. O'Connor.
1995.
Disruption of p53 function sensitizes breast cancer MCF7 cells to cisplatin and pentoxifylline.
Cancer Res.
55:1649-1654 |
| 10. | Fan, S., J. K. Chang, M. L. Smith, D. Duba, A. J. Fornace, Jr., and P. M. O'Connor. 1997. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene 14:2127-2136[CrossRef][Medline]. |
| 11. |
Ford, J. M., and P. C. Hanawalt.
1995.
Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV-resistance.
Proc. Natl. Acad. Sci. USA
92:8876-8880 |
| 12. |
Ford, J. M., and P. C. Hanawalt.
1997.
Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts.
J. Biol. Chem.
272:28073-28080 |
| 13. |
Ford, J. M.,
E. L. Baron, and P. C. Hanawalt.
1998.
Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation.
Cancer Res.
58:599-603 |
| 14. | Friedberg, E. C., G. C. Walker, and W. Siede. 1995. DNA repair and mutagenesis, p. 283-310. American Society for Microbiology Press, Washington, D.C. |
| 15. | Gaillard, P.-H., E. M. D. Martini, P. D. Kaufman, B. Stillman, E. Moustacchi, and G. Almouzni. 1996. Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor-1. Cell 86:887-896[CrossRef][Medline]. |
| 16. |
Gorospe, M.,
X. Wang, and N. J. Holbrook.
1998.
p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system.
Mol. Cell. Biol.
18:1400-1407 |
| 17. |
Griffiths, T. D., and S. Y. Ling.
1991.
Effect of UV light on DNA chain growth and replicon initiation in xeroderma pigmentosum variant cells.
Mutagenesis
6:247-251 |
| 18. |
Guzder, S. N.,
P. Sung,
L. Prakash, and S. Prakash.
1997.
Yeast RAD7-RAD16 complex, specific for nucleotide excision repair of the nontranscribed DNA strand, is an ATP-dependent DNA damage sensor.
J. Biol. Chem.
272:21665-21668 |
| 19. | Hall, P. A., J. M. Kearsey, P. J. Coates, D. G. Norman, E. Warbrick, and L. S. Cox. 1995. Characterization of the interaction between PCNA and Gadd45. Oncogene 10:2427-2433[Medline]. |
| 20. |
Hawkins, D. S.,
G. W. Demers, and D. A. Galloway.
1996.
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Cancer Res.
56:892-898 |
| 21. | Herrera, R. E., V. P. Sah, B. O. Williams, T. P. Mäkelä, R. A. Weinberg, and T. Jacks. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407[Abstract]. |
| 22. | Hollander, M. C., M. S. Sheikh, D. Bulavin, K. Lundgren, L. Augeri-Henmueller, R. Shehee, T. Molinaro, K. Kim, E. Tolosa, J. Ashwell, M. Rosenberg, Q. Zhan, P. Fernandez-Salguero, W. F. Morgan, C. Deng, and A. J. Fornace, Jr. 1999. Genomic instability in gadd45-deficient mice. Nat. Genet. 23:176-184[CrossRef][Medline]. |
| 23. |
Hwang, B. J.,
S. Toering,
U. Francke, and G. Chu.
1998.
p48 activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity.
Mol. Cell. Biol.
18:4391-4399 |
| 24. |
Hwang, B. J.,
J. M. Ford,
P. C. Hanawalt, and G. Chu.
1999.
Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair.
Proc. Natl. Acad. Sci. USA
96:424-428 |
| 25. | Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597[CrossRef][Medline]. |
| 26. |
Kaufman, P. D.,
R. Kobayashi, and B. Stillman.
1997.
Ultraviolet radiation sensitivity and reduction of telomeric silencing in Saccharomyces cerevisiae cells lacking chromatin assembly factor-1.
Genes Dev.
11:345-357 |
| 27. | Kearsey, J., P. J. Coates, A. R. Prescott, E. Warbrick, and P. A. Hall. 1995. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene 11:1675-1683[Medline]. |
| 28. | Leveillard, T., L. Andera, N. Bissonette, L. Schaeffer, L. Bracco, J.-M. Egly, and B. Waslyk. 1996. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 15:1615-1624[Medline]. |
| 29. |
Little, J. B.,
H. Nagasawa,
P. C. Keng,
Y. Yu, and C. Y. Li.
1995.
Absence of radiation-induced G1 arrest in two closely-related human lymphoblast cell lines that differ in p53 status.
J. Biol. Chem.
270:11033-11036 |
| 30. | Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967[CrossRef][Medline]. |
| 31. |
McDonald, E. R.,
G. S. Wu,
T. Waldman, and W. S. El-Deiry.
1996.
Repair defect in WAF1/CIP1 / human cancer cells.
Cancer Res.
56:2250-2255 |
| 32. |
Mellon, I., and G. N. Champe.
1996.
Products of DNA mismatch repair genes mutS and mutL are required for transcription-coupled nucleotide excision repair of the lactose operon in Escherichia coli.
Proc. Natl. Acad. Sci. USA
93:1292-1297 |
| 33. | Mitchell, D. L., J. E. Cleaver, M. P. Lowery, and R. R. Hewitt. 1995. Induction and repair of (6-4) photoproducts in normal human and xeroderma pigmentosum variant cells during the cell cycle. Mutat. Res. 337:161-167[CrossRef][Medline]. |
| 34. | Mori, T., M. Nakane, T. Hattori, T. Matsunaga, M. Ihara, and O. Nikaido. 1991. Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4) photoproduct from the same mouse immunized with ultraviolet-irradiated DNA. Photochem. Photobiol. 54:225-232[Medline]. |
| 35. |
Orr, M. S.,
W. Reinhold,
L. Yu,
N. Schreiber-Agus, and P. M. O'Connor.
1998.
An important role for the retinoblastoma protein in staurosporine-induced G1 arrest in murine embryo fibroblasts.
J. Biol. Chem.
273:3803-3807 |
| 36. |
Prost, S.,
J. M. Ford,
C. Taylor,
J. Doig, and D. J. Harrison.
1998.
Hepatitis B-x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes.
J. Biol. Chem.
273:33327-33332 |
| 37. |
Sancar, A.
1994.
Mechanisms of DNA excision repair.
Science
266:1954-1956 |
| 38. |
Smith, M. L.,
I.-T. Chen,
Q. Zhan,
I. Bae,
C.-Y. Chen,
T. M. Gilmer,
M. B. Kastan,
P. M. O'Connor, and A. J. Fornace, Jr.
1994.
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.
Science
266:1376-1380 |
| 39. | Smith, M. L., I.-T. Chen, Q. Zhan, P. M. O'Connor, and A. J. Fornace, Jr. 1995. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene 10:1053-1059[Medline]. |
| 40. | Smith, M. L., H. U. Kontny, Q. Zh |